vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and UNITIL CORP (UTL). Click either name above to swap in a different company.

UNITIL CORP is the larger business by last-quarter revenue ($161.5M vs $83.1M, roughly 1.9× PROCEPT BioRobotics Corp). UNITIL CORP runs the higher net margin — 11.8% vs -38.1%, a 49.8% gap on every dollar of revenue. On growth, UNITIL CORP posted the faster year-over-year revenue change (26.7% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -4.9%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Unitil Corporation is an interstate electricity and natural gas utility company that provides services for New Hampshire, Massachusetts and Maine. Its earliest predecessor company, the Portland Gas Light Company, was founded in Maine in 1849. The current company was set up in 1984 and is based in New Hampshire. With a market cap of 686.51M, it provides electric services to about 102,400 customers and natural gas to over 75,900 customers. The service territory of Unitil includes business distr...

PRCT vs UTL — Head-to-Head

Bigger by revenue
UTL
UTL
1.9× larger
UTL
$161.5M
$83.1M
PRCT
Growing faster (revenue YoY)
UTL
UTL
+6.5% gap
UTL
26.7%
20.2%
PRCT
Higher net margin
UTL
UTL
49.8% more per $
UTL
11.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-4.9%
UTL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
UTL
UTL
Revenue
$83.1M
$161.5M
Net Profit
$-31.6M
$19.0M
Gross Margin
64.9%
Operating Margin
-4.1%
21.5%
Net Margin
-38.1%
11.8%
Revenue YoY
20.2%
26.7%
Net Profit YoY
-27.9%
21.8%
EPS (diluted)
$-0.56
$1.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
UTL
UTL
Q1 26
$83.1M
Q4 25
$76.4M
$161.5M
Q3 25
$83.3M
$101.1M
Q2 25
$79.2M
$102.6M
Q1 25
$69.2M
$170.8M
Q4 24
$68.2M
$127.5M
Q3 24
$58.4M
$92.9M
Q2 24
$53.4M
$95.7M
Net Profit
PRCT
PRCT
UTL
UTL
Q1 26
$-31.6M
Q4 25
$-29.8M
$19.0M
Q3 25
$-21.4M
$-300.0K
Q2 25
$-19.6M
$4.0M
Q1 25
$-24.7M
$27.5M
Q4 24
$-18.9M
$15.6M
Q3 24
$-21.0M
$0
Q2 24
$-25.6M
$4.3M
Gross Margin
PRCT
PRCT
UTL
UTL
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
UTL
UTL
Q1 26
-4.1%
Q4 25
-40.6%
21.5%
Q3 25
-27.8%
6.9%
Q2 25
-28.0%
13.0%
Q1 25
-39.7%
27.0%
Q4 24
-28.9%
22.1%
Q3 24
-38.4%
6.2%
Q2 24
-50.3%
13.0%
Net Margin
PRCT
PRCT
UTL
UTL
Q1 26
-38.1%
Q4 25
-39.1%
11.8%
Q3 25
-25.7%
-0.3%
Q2 25
-24.7%
3.9%
Q1 25
-35.8%
16.1%
Q4 24
-27.6%
12.2%
Q3 24
-35.9%
Q2 24
-48.0%
4.5%
EPS (diluted)
PRCT
PRCT
UTL
UTL
Q1 26
$-0.56
Q4 25
$-0.54
$1.05
Q3 25
$-0.38
$-0.02
Q2 25
$-0.35
$0.25
Q1 25
$-0.45
$1.69
Q4 24
$-0.34
$0.97
Q3 24
$-0.40
$0.00
Q2 24
$-0.50
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
UTL
UTL
Cash + ST InvestmentsLiquidity on hand
$245.6M
$15.6M
Total DebtLower is stronger
$51.7M
$670.5M
Stockholders' EquityBook value
$347.7M
$609.6M
Total Assets
$487.1M
$2.1B
Debt / EquityLower = less leverage
0.15×
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
UTL
UTL
Q1 26
$245.6M
Q4 25
$286.5M
$15.6M
Q3 25
$294.3M
$14.6M
Q2 25
$302.7M
$8.5M
Q1 25
$316.2M
$10.2M
Q4 24
$333.7M
$6.3M
Q3 24
$196.8M
$6.3M
Q2 24
$214.1M
$2.8M
Total Debt
PRCT
PRCT
UTL
UTL
Q1 26
$51.7M
Q4 25
$51.6M
$670.5M
Q3 25
$51.6M
$670.5M
Q2 25
$51.5M
$640.7M
Q1 25
$51.5M
$642.1M
Q4 24
$51.5M
$643.3M
Q3 24
$51.4M
$643.3M
Q2 24
$51.4M
$511.3M
Stockholders' Equity
PRCT
PRCT
UTL
UTL
Q1 26
$347.7M
Q4 25
$365.9M
$609.6M
Q3 25
$380.3M
$597.2M
Q2 25
$385.8M
$532.8M
Q1 25
$389.2M
$534.1M
Q4 24
$402.2M
$512.5M
Q3 24
$241.2M
$502.4M
Q2 24
$251.8M
$508.8M
Total Assets
PRCT
PRCT
UTL
UTL
Q1 26
$487.1M
Q4 25
$508.1M
$2.1B
Q3 25
$511.5M
$1.9B
Q2 25
$513.1M
$1.9B
Q1 25
$519.4M
$1.9B
Q4 24
$534.0M
$1.8B
Q3 24
$374.1M
$1.7B
Q2 24
$374.4M
$1.7B
Debt / Equity
PRCT
PRCT
UTL
UTL
Q1 26
0.15×
Q4 25
0.14×
1.10×
Q3 25
0.14×
1.12×
Q2 25
0.13×
1.20×
Q1 25
0.13×
1.20×
Q4 24
0.13×
1.26×
Q3 24
0.21×
1.28×
Q2 24
0.20×
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
UTL
UTL
Operating Cash FlowLast quarter
$21.4M
Free Cash FlowOCF − Capex
$-36.3M
FCF MarginFCF / Revenue
-22.5%
Capex IntensityCapex / Revenue
35.7%
Cash ConversionOCF / Net Profit
1.13×
TTM Free Cash FlowTrailing 4 quarters
$-53.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
UTL
UTL
Q1 26
Q4 25
$-10.3M
$21.4M
Q3 25
$-6.6M
$15.6M
Q2 25
$-15.0M
$42.2M
Q1 25
$-17.0M
$52.1M
Q4 24
$-32.4M
$23.3M
Q3 24
$-18.8M
$26.1M
Q2 24
$-15.7M
$49.9M
Free Cash Flow
PRCT
PRCT
UTL
UTL
Q1 26
Q4 25
$-12.2M
$-36.3M
Q3 25
$-9.5M
$-39.0M
Q2 25
$-17.8M
$2.0M
Q1 25
$-18.8M
$19.5M
Q4 24
$-33.6M
$-32.3M
Q3 24
$-19.0M
$-31.3M
Q2 24
$-16.8M
$13.2M
FCF Margin
PRCT
PRCT
UTL
UTL
Q1 26
Q4 25
-15.9%
-22.5%
Q3 25
-11.4%
-38.6%
Q2 25
-22.5%
1.9%
Q1 25
-27.2%
11.4%
Q4 24
-49.2%
-25.3%
Q3 24
-32.6%
-33.7%
Q2 24
-31.4%
13.8%
Capex Intensity
PRCT
PRCT
UTL
UTL
Q1 26
Q4 25
2.4%
35.7%
Q3 25
3.4%
54.0%
Q2 25
3.5%
39.2%
Q1 25
2.7%
19.1%
Q4 24
1.7%
43.6%
Q3 24
0.4%
61.8%
Q2 24
2.0%
38.3%
Cash Conversion
PRCT
PRCT
UTL
UTL
Q1 26
Q4 25
1.13×
Q3 25
Q2 25
10.55×
Q1 25
1.89×
Q4 24
1.49×
Q3 24
Q2 24
11.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

UTL
UTL

Segment breakdown not available.

Related Comparisons